The effect of transcranial direct current stimulation on contrast sensitivity and visual evoked potential amplitude in adults with amblyopia by Ding, Zhaofeng et al.
1Scientific RepoRts | 6:19280 | DOI: 10.1038/srep19280
www.nature.com/scientificreports
The effect of transcranial direct 
current stimulation on contrast 
sensitivity and visual evoked 
potential amplitude in adults with 
amblyopia
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Junpeng Yuan1, Daming Deng1, Minbin Yu1 & Benjamin Thompson3,5
Amblyopia is a neurodevelopmental disorder of vision that occurs when the visual cortex receives 
decorrelated inputs from the two eyes during an early critical period of development. Amblyopic 
eyes are subject to suppression from the fellow eye, generate weaker visual evoked potentials (VEPs) 
than fellow eyes and have multiple visual deficits including impairments in visual acuity and contrast 
sensitivity. Primate models and human psychophysics indicate that stronger suppression is associated 
with greater deficits in amblyopic eye contrast sensitivity and visual acuity. We tested whether 
transcranial direct current stimulation (tDCS) of the visual cortex would modulate VEP amplitude and 
contrast sensitivity in adults with amblyopia. tDCS can transiently alter cortical excitability and may 
influence suppressive neural interactions. Twenty-one patients with amblyopia and twenty-seven 
controls completed separate sessions of anodal (a-), cathodal (c-) and sham (s-) visual cortex tDCS. 
A-tDCS transiently and significantly increased VEP amplitudes for amblyopic, fellow and control eyes 
and contrast sensitivity for amblyopic and control eyes. C-tDCS decreased VEP amplitude and contrast 
sensitivity and s-tDCS had no effect. These results suggest that tDCS can modulate visual cortex 
responses to information from adult amblyopic eyes and provide a foundation for future clinical studies 
of tDCS in adults with amblyopia.
Abnormal binocular visual experience during early childhood can result in amblyopia, a neurodevelopmental 
disorder of the visual cortex1,2. Amblyopia impairs a wide range of visual functions including contrast sensitivity3, 
visual acuity2, stereopsis4,5, global motion perception6,7 and contour integration8 (see9,10 for reviews). Amblyopic 
eyes also exhibit high levels of crowding11,12 and abnormal, suppressive lateral spatial interactions that are related 
to the loss of visual acuity in the affected eye13–15. The neural basis of amblyopia is yet to be fully elucidated, 
however primate models of strabismic and anisometropic amblyopia have reported weaker responses and losses 
of spatial resolution within V1 when cells were driven by the amblyopic eye compared to the fellow eye16,17. 
However, these V1 deficits were not sufficient to explain the behavioral deficits in contrast sensitivity within the 
same animals and therefore it is likely that extrastriate areas are also affected16. Indeed, abnormal responses to 
inputs from the amblyopic eye have recently been reported in V217–19 and MT20 in primate models of strabis-
mic and anisometropic amblyopia. Strong interocular suppression has also been observed within V1 and V2 in 
primate models of strabismic18 and anisometropic19 amblyopia. Importantly, in these studies, the magnitude of 
suppression was closely related to the behavioral loss of contrast sensitivity in the amblyopic eye suggesting that 
interocular suppression may play an important role in the monocular loss of contrast sensitivity that occurs in 
primate models of amblyopia18,19.
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The results of investigations into the neural basis of amblyopia in humans are broadly consistent with the 
primate neurophysiology data. Visual evoked potential (VEP) measurements have shown that stimulation of the 
amblyopic eye evokes a weaker cortical response than stimulation of the fellow eye21. Studies utilizing functional 
magnetic imaging (fMRI) have extended these findings to reveal that attenuated and abnormal responses to the 
amblyopic eye occur in V122,23, the lateral geniculate nucleus24–26, and a range of extrastriate visual areas including 
V222,23 and MT27,28. In addition, psychophysical evidence indicates that stronger suppression of the amblyopic eye 
by the fellow eye is correlated with poorer amblyopic eye visual acuity in human patients29–32. Current evidence 
also suggests that dichoptic treatment interventions designed to promote binocular vision and reduce suppression 
can improve aspects of both binocular (stereopsis) and monocular (visual acuity and contrast sensitivity) vision 
in adult patients with amblyopia33–37 (see38 for a recent review). Reduced visual cortex excitability measured using 
phosphene thresholds for single pulses of transcranial magnetic stimulation (TMS) has also been observed in 
patients with amblyopia38,39, possibly reflecting abnormally high levels of cortical inhibition. Together, these find-
ings are consistent with the idea that suppression is a key component of the amblyopia syndrome.
Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that can tran-
siently alter the excitability of targeted brain areas in a polarity specific manner40. When applied to the motor 
cortex, anodal tDCS (a-tDCS) tends to increase cortical excitability, measured as an increase in the amplitude 
of motor evoked potentials elicited by single pulse TMS40. Cathodal tDCS (c-tDCS), on the other hand, tends to 
reduce motor cortex excitability40. Comparable polarity-specific effects of tDCS on excitability have been reported 
for the visual cortex41. For example, a-tDCS of the occipital poles transiently decreases TMS phosphene thresh-
olds whereas c-tDCS has the opposite effect42,43.
One potential mechanism for the increase in cortical excitability following a-tDCS is a reduction in 
GABA-mediated inhibition within the stimulated region. Stagg et al.44 used magnetic resonance spectroscopy to 
assess the relative concentration of glutamate and GABA within the motor cortex before and after tDCS. A-tDCS 
reduced the concentration of GABA relative to glutamate whereas c-tDCS induced comparable reductions in 
both GABA and glutamate. The selective reduction of GABA concentration following motor cortex a-tDCS has 
subsequently been replicated45,46. GABA mediated inhibition has been linked to a number of suppressive neural 
interactions within the visual cortex such as those underlying surround suppression in humans and primates47–49, 
bistable perception in humans50 and interocular suppression in cats with experimentally induced strabismus51. 
Furthermore, GABA mediated inhibition has been identified as one of a number of mechanisms that regulate 
adult visual cortex plasticity in rodent models of deprivation amblyopia52. Together, these findings raise the pos-
sibility that a-tDCS may modulate visual cortex function in patients with amblyopia.
In an initial study, we found that a-tDCS of the occipital poles significantly reduced psychophysically meas-
ured surround suppression in adults with normal vision53. This result suggested that a-tDCS might act to tran-
siently reduce GABA mediated inhibition within the visual cortex as had previously been reported for the motor 
cortex44. We subsequently observed that a-, but not c-tDCS, transiently improved amblyopic eye contrast sensitiv-
ity in 8 out of 13 adult patients with strabismic and/or anisometropic amblyopia54. A-tDCS had no effect on fellow 
eye contrast sensitivity. Functional MRI measurements in 5 of these patients indicated that a-, but not sham tDCS 
(s-tDCS) significantly reduced the response bias to inputs from the fellow eye vs. the amblyopic eye in V2 and 
V354. In other words, a-tDCS reduced the cortical response asymmetry to inputs from the fellow and amblyopic 
eye in these patients.
Building on this previous work, the aim of this study was to further investigate the effects of tDCS on visual 
cortex responses and contrast sensitivity in a larger group of adults with amblyopia and controls. In particular, 
we addressed the following questions that were not part of our previous studies: 1) Are changes in amblyopic eye 
contrast sensitivity induced by tDCS associated with changes in the cortical response to inputs from the ambly-
opic eye? Cortical responses were measured using monocular pattern reversal VEPs. 2) Do the effects of tDCS on 
contrast sensitivity and VEP amplitude differ between patients with amblyopia and controls? 3) Do the effects of 
tDCS on contrast sensitivity and VEP amplitude differ significantly from a sham stimulation control condition?
Materials and Methods
Participants. Twenty-one adult participants with unilateral amblyopia (Table 1) and twenty-seven adults 
with normal vision (mean age 23.0 years, SD 2.3, range 19–30 years; 21 females) participated in this study. The 
Zhongshan Ophthalmic Center ethics committee approved the study and all study protocols were in accordance 
with the Declaration of Helsinki. Informed consent was obtained from all participants prior to data collection. 
Participants with amblyopia had an intraocular acuity difference of at least 0.2 LogMAR with no organic cause 
and 0.1 LogMAR visual acuity or better in the fellow eye. Participants with amblyopia were classified as having 
strabismic, anisometropic or mixed mechanism amblyopia (both strabismus and anisometropia). Anisometropia 
was defined as a spherical equivalent difference of 1 dioptre or more between the two eyes. Participants with 
normal vision had 0.1 LogMAR acuity or better in each eye and no history of visual disorders. Best refractive 
correction was worn during testing for all experimental sessions. No participants had a history of neurological or 
psychiatric disorder, any implanted medical devices or were currently taking medication.
Each participant took part in 7 experimental sessions; three VEP sessions, one each for anodal tDCS (a-tDCS), 
cathodal tDCS (c-tDCS) and sham tDCS (s-tDCS), and four contrast sensitivity sessions (familiarization, a-, c-, 
and s-tDCS). For control participants only one eye, selected at random, was tested.
Transcranial Direct Current Stimulation. tDCS was delivered by a battery-driven constant-current 
stimulator (Chattanooga Ionto, USA) using a pair of conductive rubber electrodes (4 mm × 6 mm stimulating 
electrode, 5 mm × 7 mm reference electrode) housed in saline-soaked synthetic sponges. A-tDCS, c-tDCS or 
s-tDCS was applied with the stimulating electrode placed over Oz and the reference over Cz. Electrode size and 
placement was adopted from previous studies of visual cortex stimulation53,54. All participants with amblyopia 
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and 12 control participants received 20 minutes of tDCS. A separate group of 15 control participants received 
10 minutes of tDCS to provide initial dose-response data for visual cortex tDCS. A- and c-tDCS were delivered at 
2 mA. Sham stimulation involved a 30 second ramp up of anodal stimulation after which the stimulator was shut 
off out of sight of the participant. Stimulation sessions were separated by at least 48 hours and a-, c- and s- tDCS 
were delivered in a random sequence. For the VEP experiment, VEPs were recorded immediately before (base-
line), after and 30 minutes after stimulation. For the contrast sensitivity experiment, measurements were made 
immediately before (baseline), during, after and 30 minutes after stimulation.
Contrast sensitivity measurements. Contrast sensitivity was measured using a 10 cpd Gabor patch 
(radius 1.3°, sigma 1°), presented on a uniform grey background (50 cd/m2) for 500 ms within a Gaussian tem-
poral envelope (100 ms ramp up and 100 ms ramp down). A relatively high spatial frequency was chosen, as the 
ID
Current Age [Age of First 
Detection]/Gender
History of Previous 




RE Aniso 0.30 + 3.00 + 0.50 × 090
LE − 0.18 + 0.25 + 0.50 × 080
02 175/M None
RE Strab (26ΔET) 0.24 + 0.25 + 0.75 × 095
LE 0.04 Plano + 1.00 × 080
03 178/M None
RE − 0.08 + 0.25–0.50 × 175
LE Mixed 
(9~17ΔET) 0.70 + 5.00 + 2.50 × 105
04 1914/M None
RE 0.26 + 6.25 + 0.50 × 090
LE 0.08 + 6.75 DS
05 17 [unknown]/ F None
RE − 0.08 − 0.25 DS
LE Aniso 1.00 + 5.00 + 1.50 × 115
06 215/ M Patching
RE Aniso 1.00 + 5.25 + 0.75 × 025
LE 0.00 + 2.75 DS
07 17 [unknown]/F None
RE − 0.08 + 0.75 DS
LE Aniso 0.40 + 4.00 + 0.75 × 085
08 1614/F None
RE Aniso 0.52 + 4.50 + 1.75 × 070
LE 0.00 − 1.00 DS
09 16 [unknown]/M None
RE Aniso 1.30 + 6.25 DS
LE 0.10 + 0.25 DS
10 1916/M None
RE Aniso 0.50 + 1.75 + 2.50 × 090
LE − 0.08 + 1.00 + 2.00 × 088
11 18 [unknown]/ M None
RE Aniso 0.30 + 1.50–4.25 × 180
LE 0.00 − 1.50 DS
12 20 [unknown]/F None
RE 0.00 + 1.00 + 0.75 × 85
LE Aniso 0.52 + 3.25 + 0.75 × 60
13 2219/ F None
RE 0.14 + 1.00–1.75 × 015
LE Aniso 0.40 + 3.50–4.25 × 170
14 2323/F None
RE − 0.1 + 1.25 + 0.50 × 105
LE Aniso 0.10 + 4.50 + 1.75 × 115
15 256/F Patching
RE − 0.08 + 4.25 DS
LE Aniso 0.84 + 5.75 + 0.50 × 105
16 216/ M Patching
RE − 0.08 + 6.00 DS
LE Strab (17ΔET) 0.56 + 5.75 + 0.25 × 160
17 177/ F Patching and Surgery
RE 0.00 Plano + 0.50 × 180
LE Aniso 1.00 + 6.50 + 1.75 × 105
18 1919/M None
RE − 0.02 − 3.25 DS
LE Aniso 0.54 + 4.50 + 1.50 × 100
19 237/M None
RE Aniso 0.30 + 4.50 DS
LE 0.00 Plano + 0.50 × 100
20 2113/M Patching
RE 0.00 + 0.25 + 0.25 × 090
LE Aniso 0.72 + 3.50 + 2.00 × 088
21 265/F None
RE 0.00 + 5.00 DS
LE Mixed (17ΔET) 0.72 + 6.00 DS
Table 1.  Clinical details of the participants with amblyopia. M, male, F, female, RE, right eye, LE, left eye, 
Aniso, anisometropic amblyopia, Strab, strabismic amblyopia, DS, diopter sphere.
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effects of amblyopia on contrast sensitivity are most pronounced at high spatial frequencies3. On each trial, par-
ticipants judged the orientation of the patch (vertical vs. horizontal). Stimuli were generated using Psykinematix 
software, which allows for 10.8 bits of contrast resolution, and presented on an Eizo CRT monitor (1024 × 768 res-
olution, 120 Hz refresh rate). The viewing distance was 200 cm and a tight fitting opaque patch was worn over the 
non-viewing eye.
A two-alternative forced choice (2AFC) paradigm and a 2-down-1-up adaptive staircase procedure (propor-
tional step size of 25% before the first reversal and 7.5% increments and 15% decrements after the first reversal) 
was used to measure detection thresholds. Thresholds were calculated as the mean of the last four reversals out 
of a total of six reversals. Participants completed at least 1 hour of task familiarization in a separate session prior 
to the tDCS sessions. The order of the a-, c- and s-tDCS sessions was randomized across participants. Contrast 
sensitivity was measured before, during, after and 30 minutes after tDCS. Only a single spatial frequency was 
measured because tDCS can only be administered for a finite period of time and the after-effects can decay 
rapidly. Therefore we did not anticipate that there would be time to measure a full contrast sensitivity function.
Pattern visual evoked potentials. The VEP stimuli were standard black (5 cd/m2) and white (80 cd/m2) 
pattern-reversal checkerboards generated with a Roland Consult clinical electrophysiology system viewed from 
100 cm with a temporal frequency of 2 Hz. The stimuli were presented with a resolution of 1280 × 1024 at two 
contrasts (100% and 50% contrast) and two check sizes (15′ and 60′ , equating to a fundamental spatial frequency 
of 2 cpd and 0.5 cpd respectively). VEPs for each of the 4 stimuli were collected at each time point (pre, post and 
30 minutes post tDCS) in a random sequence. For participants with amblyopia, the fellow eye was always tested 
first. Measurements conformed to the ISCEV standards for clinical VEP recording. The non-viewing eye was 
occluded with a tight fitting opaque patch.
Data analysis. Contrast detection thresholds were converted to log contrast sensitivity. VEP amplitude was 
defined as the difference between the N75 negative peak and the P100 positive peak amplitudes in μ V. Using this 
difference rather than absolute values facilitated the comparison of VEP data across separate sessions. The N75 
peak was defined as a negative peak 60 to 110 ms after the pattern reversal. The peak of the first positive wave 
after the N75 peak was defined as the P100. Latencies for both the N75 and P100 were also calculated. Changes 
from pre-stimulation baseline within each session were calculated by subtraction of the baseline value from the 
subsequent values within the session.
Four ANOVAs were conducted on the change from baseline data for contrast sensitivity to compare the 
effects of a-, c- and s-tDCS on the amblyopic, fellow fixing and control eyes and to compare the effects of 10 and 
20 minutes of tDCS in control participants. 1) An ANOVA with factors of Eye (amblyopic vs. fellow fixing eye), 
Stimulation (anodal vs. cathodal vs. sham) and Time (during vs. post vs. post 30 minutes) was conducted on 
the results from the observers with amblyopia. 2) A mixed ANOVA with within-subject factors of Stimulation 
(anodal vs. cathodal vs. sham) and Time (during vs. post vs. post 30 minutes) and a between-subjects factor 
of Eye (amblyopic vs. control) was conducted on the data from participants with amblyopia and controls who 
received 20 minutes of tDCS. 3) A mixed ANOVA with within-subject factors of Stimulation (anodal vs. cathodal 
vs. sham) and Time (during vs. post vs. post 30 minutes) and a between-subjects factor of Eye (fellow fixing eye 
vs. control) was conducted on the data from participants with amblyopia and controls who received 20 minutes 
of tDCS. 4) A mixed ANOVA with within-subject factors of Stimulation (anodal vs. cathodal vs. sham) and Time 
(during vs. post vs. post 30 minutes) and a between-subjects factor of tDCS Duration (20 minutes vs. 10 minutes) 
was conducted on the data from controls who received either 20 or 10 minutes of tDCS.
Post-hoc paired samples t-tests were used to compare contrast sensitivity changes induced by c- or a-tDCS to 
the within session baseline and s-tDCS. Pearson’s correlation was employed to evaluate the relationship between 
the mean contrast sensitivity change (the mean of the during, post and post 30 minutes changes) and the severity 
of amblyopia.
The same analysis approach was applied to the VEP amplitude and latency data. Additional within-subjects 
factors of Spatial frequency (15′ vs 60′ ) and Contrast (50% vs. 100%) were added to the four ANOVAs and the 
‘during stimulation’ timepoint was removed from the analysis as this was not collected for the VEP experiments 
due to technical constraints. Pearson’s correlation was employed to evaluate the relationship between the mean 
VEP change (the mean of post and post 30 minutes changes) and severity of amblyopia.
Finally Pearson’s correlations between the average changes in contrast sensitivity and the average changes in 
the VEP amplitude following anodal tDCS were conducted for four data sets; amblyopic eyes, fellow fixing eyes, 
control eyes (20 min tDCS) and control eyes (10 min tDCS).
Results
We first assessed the effect of a-tDCS on pattern reversal VEPs (statistical results are provided in Tables 2 and 3). 
VEP amplitude was significantly weaker at baseline for amblyopic eyes than fellow eyes for each session. The 
mean baseline VEP amplitude for amblyopic eyes collapsed across stimulus contrast, spatial frequency and ses-
sion was 6.95 ± 3.44 uV compared to 10.84 ± 5.09 uV for fellow eyes (t20 = 4.316, p < 0.001).
A-tDCS increased the amplitude of the pattern reversal VEP for amblyopic, non-amblyopic and control eyes 
directly after and 30 minutes after stimulation (Fig. 1). This effect was significantly different from s-tDCS and 
c-tDCS and was not dependent on the spatial frequency or contrast of the standard checkerboard VEP stimulus. 
Conversely, c-tDCS reduced the amplitude of the VEP and sham had no effect. VEP latencies were unaffected 
by tDCS suggesting that the effect was restricted to the response of cortical neurons and did not influence con-
duction time from retina to cortex. For controls, reducing the stimulation duration to ten minutes did not sig-
nificantly alter the effects, although the c-tDCS induced decreases in VEP amplitude were more pronounced. 
Representative VEP waveforms are shown in Fig. 2.
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The results for contrast sensitivity were consistent with the VEP measurements. Amblyopic eye contrast sen-
sitivity was significantly lower than that of the fellow eye for all baseline sessions (mean log sensitivity collapsed 
across sessions; amblyopic eye = 0.70 ± 0.52, fellow eye = 1.66 ± 0.34; t20 = 7.34, p < 0.001). A-tDCS significantly 
improved contrast sensitivity whereas c-tDCS had the opposite effect (Fig. 3; Tables 4 and 5). Contrast sensitivity 
measurements for two participants showed a large reduction in sensitivity following sham stimulation for the 
non-amblyopic eye condition only. This effect did not occur for other participants and is reflected in the standard 
error of the sham data in Fig. 3B.
No significant relationships were found between amblyopic eye visual acuity at baseline and the a-tDCS 
induced changes in contrast sensitivity (Fig. 4A) or VEP amplitude (Fig. 4B) for amblyopic eyes. Data were col-
lapsed across the ‘during’, ‘post’ and ‘post 30’ time points for correlation analyses. Changes in contrast sensitivity 
induced by a-tDCS and the changes in VEP amplitude induced by a-tDCS were also not significantly correlated 
(Fig. 5).
Given the significant increases in VEP amplitude and contrast sensitivity following a-tDCS, we investigated 
the duration of the effects. For the VEP measurements, fourteen participants with amblyopia completed a-tDCS 
as their first or second tDCS session and therefore completed a baseline measurement 48 hours later. There was a 
significant increase in VEP amplitude from the a-tDCS baseline to the baseline 48 hours later (t13 = 3.8, p = 0.002) 
suggesting an enduring effect of the a-tDCS. This did not occur for sham stimulation (n = 12, t11 = 1.5, p = 0.2). 
Post a-tDCS baselines did not differ significantly from pre a-tDCS baselines for amblyopic eye contrast sensitivity 
(n = 13, t12 = 2.0, p = 0.07).
Discussion
Our results demonstrate that a single session of a-tDCS can transiently increase VEP amplitude and contrast 
sensitivity in adult patients with amblyopia. Specifically, a-tDCS increased VEP amplitude and contrast sensitivity 
for amblyopic eyes. Similar effects were found for control eyes, however fellow eyes of patients with amblyopia 
did not show increased contrast sensitivity following a-tDCS. Importantly, increases did not occur following c- or 
s-tDCS, indicating that the effects were specific to a-tDCS and were not due to within session learning.
The results of this study contribute to a growing literature indicating that non-invasive brain stimulation can 
modulate contrast sensitivity in adults with amblyopia39,54,55. A possible mechanism for the a-tDCS effects we 
report is reduced inhibition within the visual cortex. Visual input from the amblyopic eye is subject to atten-
uation56 and suppression18,19,31 which may contribute to the weakened cortical response to information from 
the amblyopic eye22. The magnitude of suppression is positively correlated with the loss of visual acuity29–32 and 
contrast sensitivity18,19 in humans and primates with strabismic or anisometropic amblyopia, and reducing sup-
pression may result in improvements in both visual acuity and stereopsis33,36,57. This suggests that suppression 
is an important contributor to the visual deficits associated with amblyopia. The inhibitory neurotransmitter 
GABA is involved in suppression of cortical inputs from one eye in cat models of strabismus51. GABA has also 
been implicated as one of a suite of mechanisms that gate recovery from amblyopia in adult rodents52. This role 
of GABA is directly relevant to a-tDCS effects because magnetic resonance spectroscopy measurements have 
shown that a-tDCS reduces the relative concentration of GABA when applied to the motor cortex44. Furthermore, 
a-tDCS induced reductions in motor cortex GABA have been associated with enhanced learning of a motor task, 
providing a link between changes in GABA and behavioral performance46. It is possible that a-tDCS reduces 
GABA within the visual cortex and therefore reduces chronic suppression of inputs from the amblyopic eye. This, 
combined with the excitatory effects of a-tDCS, may lead to a transient enhancement of the cortical response to 
amblyopic eye inputs in the form of an increased VEP amplitude and improved contrast sensitivity. Future work 
will test this hypothesis by assessing the effect of a-tDCS on measures of interocular suppression in patients with 
amblyopia.
We observed a dissociation between the a-tDCS induced increases in VEP amplitude that occurred for 
all eyes and the increases in contrast sensitivity that only occurred for amblyopic and control eyes. Fellow 
ANOVA factor(s) AME vs. FEE AME vs. Control FFE vs. Control Control 10 vs. 20 min
Stimulation (a-tDCS vs. c-tDCS vs. s-tDCS) F2, 40 = 57.840, p < 0.001 F2, 62 = 36.227, p < 0.001 F2, 62 = 30.622, p < 0.001 F2, 50 = 21.441, p < 0.0001
Time (pre vs. post vs. 30 min post) F1, 20 = 0.088, p = 0.769 F1, 31 = 4.462, p = 0.043 F1, 31 = 0.574, p = 0.454 F1, 25 = 17.490, p < 0.0001
Eye (amblyopic vs. fellow) F1, 20 = 9.723, p = 0.005
SF (low vs. high) F1, 20 = 0.483, p = 0.495 F1, 31 = 2.415, p = 0.13 F1, 31 = 0.146, p = 0.705 F1, 25 = 0.005, p = 0.946
Contrast (low vs. high) F1, 20 = 2.794, p = 0.609 F1, 31 = 2.093, p = 0.158 F1, 31 = 0.335, p = 0.567 F1, 25 = 11.092, p = 0.003
Stimulation*Time F2, 40 = 0.804, p = 0.455 F2, 62 = 0.509, p = 604 F2, 62 = 1.643, p = 0.202 F2, 50 = 2.452, p = 0.98
Stimulation*Eye F2, 40 = 3.985, p = 0.026
Stimulation*SF F2, 40 = 0.21, p = 0.811 F2, 62 = 0.672, p = 0.514 F2, 62 = 0.457, p = 0.635 F2, 50 = 0.176, p = 0.838
Stimulation*Contrast F2, 40 = 0.765, p = 0.472 F2, 62 = 0.175, p = 0.84 F2, 62 = 0.531, p = 0.591 F2, 50 = 0.196, p = 0.818
Stimulation*Time*Eye F2, 40 = 0.804, p = 0.454
Stimulation*Eye (between-subjects factor) F2, 62 = 1.476, p = 0.236 F2, 62 = 4.708, p = 0.012
Stimulation*tDCS Duration (between-
subjects factor) F2, 50 = 2.767, p = 0.073
Table 2.  The results of ANOVAs testing the effect of tDCS on VEP amplitudes. AME, amblyopic eye, FFE, 
fellow fixing eye.
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VEP data t-tests Post Post30
AME
Anodal t20 = 6.256, p < 0.001 t20 = 6.351, p < 0.001
Cathodal t20 = − 5.276, p < 0.001 t20 = − 3.225, p = 0.004
Sham t20 = − 0.44, p = 0.662 t20 = 1.724, p = 0.1
Anodal vs. Sham t20 = 6.129, p < 0.001 t20 = 4.293, p < 0.001
Cathodal vs. Sham t20 = − 4.107, p = 0.001 t20 = − 4.188, p < 0.001
FEE
Anodal t20 = 3.517, p = 0.002 t20 = 3.267, p = 0.004
Cathodal t20 = − 4.912, p < 0.001 t20 = − 8.596, p < 0.001
Sham t20 = − 1.359, p = 0.189 t20 = − 0.751, p = 0.461
Anodal vs. Sham t20 = 3.483, p = 0.002 t20 = 3.148, p = 0.005
Cathodal vs. Sham t20 = − 4.852, p < 0.001 t20 = − 5.263, p < 0.001
Control 20 min
Anodal t11 = 2.792, p = 0.018 t11 = 5.190, p < 0.001
Cathodal t11 = − 1.020, p = 0.33 t11 = − 1.27, p = 0.23
Sham t11 = − 0.868, p = 0.404 t11 = 0.018, p = 0.986
Anodal vs. Sham t11 = 2.781, p = 0.018 t11 = 5.067, p < 0.001
Cathodal vs. Sham t11 = − 0.795, p = 0.443 t11 = − 1.344, p = 0.206
Control 10 min
Anodal t14 = 1.864, p=0.082 t14 = 3.296, p = 0.005
Cathodal t14 = − 4.598, p < 0.0001 t14 = − 5.297, p < 0.0001
Sham t14 = 0.76, p = 0.486 t14 = 2.091, p = 0.055
Anodal vs. Sham t14 = 0.961, p = 0.353 t14 = 1.363, p = 0.194
Cathodal vs. Sham t14 = − 4.032, p = 0.001 t14 = − 5.228, p < 0.001
Table 3.  The results of within subjects t-tests comparing the effects of tDCS on VEP amplitudes to within 
session baselines and the sham condition. AME, amblyopic eye, FFE, fellow fixing eye. Unless indicated with 
“vs. Sham” the post hoc t-tests compare each condition to the within session baseline. Positive t values indicate 
an increase in VEP amplitude and negative values indicate a decrease.
Figure 1. A-tDCS increased the amplitude of the pattern reversal VEP. The change in VEP amplitude from 
baseline after 20 minutes of anodal, cathodal or sham tDCS is shown for amblyopic (A; n = 21), non-amblyopic 
(B; n = 21) and control (C; n = 12) eyes. Positive values indicate an improvement. Measurements were made 
directly after (Post) and 30 minutes after (Post30) simulation. For controls, reducing the simulation duration 
to 10 minutes did not change the pattern of tDCS effects (D; n = 15). * = significant change from baseline, 
“ = significant difference from sham (paired t-test, p < 0.05).
eyes did not show significant improvements in contrast sensitivity relative to baseline following a-tDCS. The 
increases in VEP amplitude are likely to reflect increased cortical excitability, a well-documented effect of 
a-tDCS within the motor cortex40. Therefore, our results suggest that the contrast sensitivity improvements 
induced by a-tDCS are not solely due to increased excitability. This finding raises the possibility that the 
improvements in contrast sensitivity may be more closely related to reduced inhibition/suppression within 
the visual cortex. While the control observers did not exhibit suppression under normal viewing conditions, 
a level of binocular competition or rivalry was introduced by the monocular viewing conditions used within 
the experiment (i.e. patching of the non-viewing eye). This may have been reduced by a-tDCS, leading to 
enhanced contrast sensitivity relative to baseline and sham. On the other hand, patching of the amblyopic 
eye would not induce rivalrous conditions for the fellow eye because suppressive interactions are biased in 
favor of the fellow eye18. Therefore no improvements in fellow eye contrast sensitivity would be expected 
following a-tDCS if reduced inhibition is involved.
An alternative explanation relates to the concept of homeostatic metaplasticity, whereby non-invasive brain 
stimulation acts to return a neural system to homeostasis58. Under this explanation, a-tDCS would have had a 
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Figure 2. Example VEP Reponses for an amblyopic eye (Patient 19), a fellow eye (Patient 19) and a control 
eye before (baseline), after and 30 minutes after a-tDCS. The right column identifies the size of the check in 
the VEP stimulus (either 60′ or 15′ ) and the contrast (either 50% or 100%). Each waveform is the average of 64 
repetitions.
Figure 3. A-tDCS enhanced contrast sensitivity. The change in log contrast sensitivity relative to baseline 
after 20 minutes of anodal, cathodal or sham tDCS is shown for amblyopic (A), non-amblyopic (B) and control 
(C) eyes. Positive values indicate an improvement. Measurements were made during (Dur), directly after (Post) 
and 30 minutes after (Post30) simulation. For controls, reducing the stimulation duration to 10 minutes did not 
change the pattern of results (D). * = Significant change from baseline, “ = significant difference from sham 
(paired t-test, p < 0.05).
www.nature.com/scientificreports/
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ANOVA factor(s) AME vs. FEE AME vs. Control FFE vs. Control Control 10 vs. 20 min
Stimulation F2, 40 = 12.364, p < 0.001 F2, 72 = 24.798, p < 0.001 F2, 72 = 11.069, p < 0.001 F2, 58 = 26.909, p < 0.0001
Time F2, 40 = 0.997, p = 0.378 F2, 72 = 0.326, p = 0.723 F2, 72 = 2.067, p = 0.134 F2, 58 = 2.174, p = 0.128
Eye F1, 20 = 4.381, p = 0.049
Stimulation*Time F4, 80 = 3.516, p = 0.011 F4, 144 = 0.473, p = 0.755 F4, 144 = 1.657, p = 0.163 F2, 116 = 0.156, p = 0.960
Stimulation*Eye F2, 40 = 0.936, p = 0.4
Stimulation*Time*Eye F4, 80 = 0.321, p = 0.863
Stimulation*Eye (between-subjects factor) F2, 72 = 0.056, 0.946 F2, 72 = 0.796, p = 0.455
Stimulation*tDCS Duration (between-
subjects factor) F2, 58 = 0.102, p = 0.903
Table 4.  The results of ANVOAs testing the effect of tDCS on log contrast sensitivity. Data reported as in 
Table 2.
VEP data t-tests Dur Post Post30
AME
Anodal t20 = 2.262, p = 0.035 t20 = 2.623, p = 0.016 t20 = 2.855, p = 0.01
Cathodal t20 = − 1.841, p = 0.08 t20 = − 2.453, p = 0.023 t20 = − 1.903, p = 0.072
Sham t20 = − 0.66, p = 0.948 t20 = − 0.463, p = 0.648 t20 = − 0.107, p = 0.916
Anodal vs. Sham t20 = 1.593, p = 0.127 t20 = 2.429, p = 0.025 t20 = 2.362, p = 0.028
Cathodal vs. Sham t20 = − 1.375, p = 0.184 t20 = − 1.729, p = 0.99 t20 = − 1.451, p = 0.162
FEE
Anodal t20 = 0.257, p = 0.8 t20 = − 0.146, p = 0.885 t20 = 1.367, p = 0.187
Cathodal t20 = 0.892, p = 0.383 t20 = − 2.225, p = 0.038 t20 = − 3.294, p = 0.004
Sham t20 = − 0.963, p = 0.347 t20 = − 2.007, p = 0.058 t20 = − 1.696, p = 0.105
Anodal vs. Sham t20 = 0.97, p = 0.343 t20 = 1.845, p = 0.08 t20 = 2.372, p = 0.028
Cathodal vs. Sham t20 = 0.229, p = 0.821 t20 = 0.411, p = 0.685 t20 = − 0.382, p = 0.706
Control 20 min
Anodal t16 = 4.945, p < 0.001 t16 = 4.550, p < 0.001 t16 = 3.208, p = 0.005
Cathodal t16 = − 3.064, p = 0.007 t16 = − 3.240, p = 0.005 t16 = − 2.351, p = 0.032
Sham t16 = 0.437, p = 0.668 t16 = − 0.149, p = 0.883 t16 = 0.369, p = 0.717
Anodal vs. Sham t16 = 4.095, p = 0.001 t16 = 3.244, p = 0.005 t16 6 = 2.165, p = 0.046
Cathodal vs. Sham t16 = − 2.456, p = 0.026 t16 = − 2.358, p = 0.031 t16 = − 1.866, p = 0.081
Control 10 min
Anodal t13 = 3.449, t = 0.004 t13 = 4.007, p = 0.001 t13 = 4.282, p = 0.001
Cathodal t13 = − 1.346, p = 0.201 t13 = − 0.489, p = 0.633 t13 = − 0.938, p = 0.365
Sham t13 = 0.017, p = 0.986 t13 = 1.539, p = 0.148 t13 = 1.961, p = 0.072
Anodal vs. Sham t13 = 2.874, p = 0.013 t13 = 2.833, p = 0.014 t13 = 2.860, p = 0.013
Cathodal vs. Sham t13 = − 1.368, p = 0.194 t13 = − 1.168, p = 0.264 t13 = − 2.007, p = 0.066
Table 5.  The results of t-tests comparing the effects of tDCS on log contrast sensitivity to the within session 
baseline and the sham condition. Data reported as in Table 3.
greater effect on neural populations preferring information from the amblyopic eye that have low levels of base-
line activation. This explanation would also account for the trend towards more pronounced inhibitory effects of 
c-tDCS on fellow eye VEP amplitudes and contrast sensitivity. This is because fellow eye neural populations have 
a higher level of activation22 and are therefore likely to be more susceptible to the effects of inhibitory stimulation 
protocols. It is unclear how homeostatic metaplasticity relates to our control eye results. Based on the current 
data, we are not able to discriminate between these two explanations.
In addition to its effects on GABA, tDCS may also enhance expression of brain derived neurotropic 
factor (BDNF)59 and increased BDNF levels have been linked with recovery from adult amblyopia in ani-
mal models60. Furthermore, the aftereffects of tDCS rely on the function of NMDA receptors61. This has 
led to the suggestion that a-tDCS has long term potential (LTP) - like effects. NMDA receptor dependent 
changes in synaptic strength have been linked to recovery of ocular dominance plasticity animal models of 
amblyopia62 and may underlie the increases in VEP amplitude and contrast sensitivity we report. We favor 
an explanation based on temporary changes in inhibition and excitation because LTP and BDNF effects are 
gradual, whereas the effects we observed were rapid. It is possible, however, that LTP-like changes underlie 
the longer-term effects of a-tDCS on VEP amplitude that we observed for amblyopic eyes 48 hours after 
stimulation.
Previous studies into the effects of tDCS on the healthy visual cortex have generated conflicting results. In 
terms of VEPs, a-tDCS has been reported to increase and c-tDCS decrease VEP amplitude63, however opposite 
results have also been observed64. Furthermore, tDCS has been reported to have no effect on flash VEPs65. The 
results from previous studies investigating tDCS induced changes in contrast sensitivity are similarly varia-
ble. Antal et al.66 found that c-tDCS decreased static and dynamic contrast sensitivity, whereas a-tDCS had 
no reliable effect. Using threshold perimetry, Kraft et al.67 found that a-tDCS enhanced contrast sensitivity 
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within the central 2 degrees of the visual field whereas c-tDCS had no effect. More recently Costa et al.68 also 
found that a-tDCS increased contrast sensitivity on threshold perimetry, but only in the periphery. Finally, 
an absence of acute tDCS effects on contrast sensitivity have been reported53,69. These discrepancies could be 
due to differences in visual stimuli, viewing conditions, tDCS parameters and electrode placement. However, 
individual differences between the participants taking part in each of these studies may also contribute to these 
discrepancies as a number of factors such as BDNF polymorphisms and hormone levels have been found to 
alter the response to tDCS70. In the current study, electrophysiological and behavioral measures were made in 
the same participants and the polarity specific effects were consistent across both measures; a-tDCS tended to 
increase VEP amplitude and contrast sensitivity whereas c-tDCS had the opposite effect. These results are in a 
good agreement with the established polarity dependent effects of motor cortex tDCS40 and support the use of 
tDCS to modulate visual cortex function.
Reducing the duration of tDCS to 10 minutes did not change the pattern of results in control participants. 
Whether this is also the case for patients with amblyopia remains to be tested. The effect of repeated doses of 
a-tDCS also remains an open question and the exploration of ways to prolong the effects of a-tDCS is an impor-
tant next step in this field.
Although the effects of tDCS were consistent between the VEP and contrast sensitivity measurements, we did 
not find a direct correlation between the changes in VEP and changes in contrast sensitivity. This may be due to 
the very different nature of the stimuli used to elicit VEPs and measure contrast sensitivity. The lack of a direct 
correlation may also reflect different neural mechanisms for the two effects, as described above.
These results indicate that a-tDCS can temporarily increase contrast sensitivity in adults with amblyopia in 
agreement with previous studies54. It has also previously been reported that a-tDCS can enhance the effect of 
dichoptic treatment on stereopsis in adults with amblyopia71. Further work using standard clinical outcome meas-
ures such as visual acuity is required to assess whether a-tDCS alone has any clinical relevance for the treatment 
of amblyopia in adulthood.
Figure 4. Relationships between amblyopia severity and tDCS induced changes in VEP amplitude (A) and 
contrast sensitivity (B). 
Figure 5. Correlations between the effects of anodal tDCS on contrast sensitivity and VEP amplitude for 
amblyopic eyes (Panel A), fellow fixing eyes (Panel B), control eyes 10 min tDCS (Panel C) and control eyes 
20 minutes tDCS (Panel D). The change in contrast sensitivity and VEP amplitude were collapsed across time 
points.
www.nature.com/scientificreports/
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